A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) - Merck Sharp & Dohme LLCSee more
Hiv
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053) - Merck Sharp & Dohme LLCSee more